Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of radiation therapy and gadolinium texaphyrin in
treating patients who have supratentorial glioblastoma multiforme. Radiation therapy uses
high-energy x-rays to damage tumor cells. Drugs such as gadolinium texaphyrin may make the
tumor cells more sensitive to radiation therapy.